About
Snakebite treatment
Areas of Focus
Categories
Small Molecule PharmaceuticalBiotech
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
253
By Phase
PHASE2: 3
By Status
COMPLETED: 2TERMINATED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05717062Lead Sponsor
Broad-spectrum Rapid Antidote: Varespladib IV to Oral Trial for Snakebite (BRAVIO)
PHASE2Completed
140 participants
Started: May 30, 2023 · Completed: Feb 24, 2025
NCT04996264Lead Sponsor
Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite
PHASE2Completed
95 participants
Started: Aug 15, 2021 · Completed: Jun 8, 2023
NCT04969991Lead Sponsor
Study of Varespladib in Patients Hospitalized With Severe COVID-19
PHASE2Terminated
18 participants
Started: Jun 30, 2021 · Completed: Nov 22, 2022
Locations (1)
Headquarters
San Francisco, CA, United States
Map
Loading map...